CRSP insider trading
Open-market stock trades by CRISPR Therapeutics (CRSP) executives and directors: who bought or sold, how many shares, at what price and when.
CRSP insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Kulkarni Samarth | Chief Executive Officer | Sell | 47,837 | $49.78 | $2.38M |
| Oct 14, 2026 | George Simeon | director | Sell | 14,514 | $49.63 | $720.37K |
| Oct 14, 2026 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,040 | $49.26 | $51.23K |
| Oct 14, 2026 | Kulkarni Samarth | Chief Executive Officer | Sell | 4,098 | $49.26 | $201.87K |
| Oct 6, 2026 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,990 | $60.04 | $119.48K |
| Sep 22, 2026 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 10,400 | $60.24 | $626.46K |
| Sep 17, 2026 | Behbahani Ali | director | Sell | 13,679 | $57.09 | $780.94K |
| May 29, 2026 | Patel Naimish | Chief Medical Officer | Sell | 3,786 | $55.62 | $210.58K |
| Mar 23, 2026 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,182 | $46.78 | $148.85K |
| Mar 23, 2026 | Kulkarni Samarth | Chief Executive Officer | Sell | 10,020 | $46.78 | $468.74K |
| Mar 23, 2026 | Prasad Raju | Chief Financial Officer | Sell | 3,708 | $46.78 | $173.46K |
| Mar 16, 2026 | Patel Naimish | Chief Medical Officer | Sell | 3,150 | $48.26 | $152.02K |
| Mar 16, 2026 | Prasad Raju | Chief Financial Officer | Sell | 5,848 | $48.26 | $282.22K |
| Mar 16, 2026 | Prasad Raju | Chief Financial Officer | Sell | 4,021 | $48.26 | $194.05K |
| Mar 16, 2026 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,450 | $48.26 | $166.50K |
| Mar 16, 2026 | Kulkarni Samarth | Chief Executive Officer | Sell | 10,349 | $48.26 | $499.44K |
| Mar 11, 2026 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,800 | $52.80 | $147.84K |
- CRSP insiders bought $0.00 and sold $7.33M in open-market trades over their last 17 filings.
Updated 2026-11-02 23:13 UTC